Tech Trail
-
The critical role of crossover investors
The landmark sale of Kymab to Sanofi for £1.45 billion set thoughts racing among life science entrepreneurs around the world and, particularly, in... Read More
-
Parkwalk launches groundbreaking DeepTech fund
Parkwalk Advisors has launched a novel fund to boost investment in DeepTech businesses spun out of UK universities such as Cambridge and the new... Read More
-
Zoom funders back £6.2m seed round for Cambridge startup’s war on plastic pollution
Cambridge University spin-out Xampla has closed a £6.2 million seed round, led by the backers of Zoom, to accelerate roll-out of its next generation... Read More
-
Owlstone breath solution offers detection hope for range of diseases
Unsurprising given how the COVID-19 virus spreads, 2020 has seen a rise in global interest for the fast-growing field of breath research. The... Read More
-
Funders back Spirea’s novel payload flexibility for cancer therapeutics
Cambridge University spin-out Spirea – founded to deliver nextgen antibody drug conjugate (ADC) cancer therapeutics – has secured unspecified funding... Read More
-
Cambridge Innovation Capital co-leads £7.1m Series A in ML powerhouse
Cambridge Innovation Capital and AlbionVC have co-led a £7.1 million Series A investment in a cloud agnostic machine learning company set for... Read More
-
Genetics advancement is in Cambridge’s DNA
Congenica’s stunning $50 million Series C last week and the backing of investors from the UK, China, Malaysia and Oman said a number of things about... Read More
-
o2h ventures leads HMRC-backed bio funding revolution
Cambridge based o2h ventures has launched its HMRC-approved knowledge intensive EIS fund, focusing on supporting the expansion of UK... Read More
-
CMS Ventures invests in Cambridge AI MedTech startup
Cambridge imaging analytics company Qureight has clinched £500K in seed funding from CMS Ventures, a move which will enable the startup to launch the... Read More
-
Morningside Ventures leads $53.4m Series B in Immune Regulation
Immune Regulation, a US and Cambridge UK based clinical stage biotechnology company has raised a $53.4 million Series B round led by Morningside... Read More
-
Medicxi invests €200m in super six biotechs
Medicxi – whose founding partner and chief scientist, David Grainger, operates internationally from a Cambridge base – is claiming a world first... Read More
-
IntelliSense.io strikes gold again with major new funding round
Cambridge AI business IntelliSense.io has triggered a global expansion programme after securing what it calls major investment capital led by German-... Read More
-
EMBL-EBI embraces HPC powerhouse at Kao Data campus
In the heart of the UK Innovation Corridor, a hop, skip and a jump away from Cambridge, lies the future of High Performance Computing (HPC) –... Read More
-
Mursla raising cash to advance cancer innovation technology
Mursla, a Cambridge University liquid biopsy spin-out, has raised £410K from the UK Government’s Future Fund and existing investors plus a £40K COVID... Read More
-
VividQ one of the top deals for Cambridge VC
Behind most exciting spin-outs from academia stands a top notch venture capitalist and AR display startup VividQ with expertise in holography is a... Read More
-
IntelliSense.io mines fresh growth capital from BASF
German power player BASF Venture Capital (BVC) has led a strategic investment round – sum unspecified – in Cambridge industrial artificial... Read More
-
MedTech startup raises $1.7 million for US push
Cambridge-born medical software business Transformative AI has raised a $1.7 million seed round. Trade Mark and patent attorney Mathys &... Read More
-
Spotta’s smart pest systems attracts $1.18m seed funding from US and UK
Investors have rewarded the commercial success of Cambridge startup Spotta’s smart pest systems technology with a $1.18 million seed funding round.... Read More
-
Talented twosome promoted by Amadeus Capital Partners
Global technology investor Amadeus Capital Partners – which has major operations in Cambridge – has promoted Amelia Armour and Pierre Socha to... Read More
-
Cambridge Enterprise leads funding round for FinTech starlet
Cambridge Enterprise, the commercialisation arm of the University of Cambridge, has provided follow-on investment for Bond180, a provider of... Read More